1 / 22

Drug Research Unit Maastricht

Drug Research Unit Maastricht. The Early Phase (0-I-II) Clinical Drug Research Unit of Maastricht University Medical Center (MUMC) prof dr L. Van Bortel. Mission Statement. To contribute to the development of new drugs by conducting early phase clinical trials (phase 0-I-II)

yachi
Download Presentation

Drug Research Unit Maastricht

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Drug Research Unit Maastricht The Early Phase (0-I-II) Clinical Drug Research Unit of Maastricht University Medical Center (MUMC)prof dr L. Van Bortel

  2. Mission Statement To contribute to the development of new drugs by conducting early phase clinical trials (phase 0-I-II) in compliance with (inter)national legislation and quality standards

  3. Position in MUMC-holding/valorisation chain • essential part in chain of drug development preclinical→ early phase →phase 3&4 • by filling the gap in the drug research chain • facilitates translational research

  4. Strategic alliance Close collaboration with Drug Research Unit Ghent (DRUG): 1 CEO for 2 units • ↑ possibilities of conducting larger trials or trials with difficult recruitment • DRUM can take advantage of the elaborated quality management system and training at DRUG • Joint PR for internal and external sponsors • Cross-fertilisation of know-how/methods …

  5. sponsors • Pharmaceutical industry (+ nutriceuticals) • Non for profit organisations • MUMC • Other University departments

  6. What can DRUM offer sponsors State of the art conduct of early phase clinical studies • High quality • Large expertise • Short timelines • High flexibility • Fair cost

  7. What can DRUM offer sponsors State of the art conduct of early phase clinical studies • High quality • Large expertise • Short timelines • High flexibility • Fair cost

  8. Quality quality control • first party (internal) audits • scheduled on main procedures • ad hoc for (near) errors • training in SOP (all SOP’s revised within 2 yrs) • close feedback on the spot / approval system quality assurance • 1 GCP-ICH third party audit/yr • ISO 9001:2008 → 1 ISO audit/yr (within 1 year?)

  9. What can DRUM offer sponsors State of the art conduct of early phase clinical studies • High quality • Large expertise • Short timelines • High flexibility • Fair cost

  10. Large expertise takes advantage of experts in 2 knowledge centers: MUMC - U(Z)Gent → many therapeutic areas → high tec investigations experience in early phase clinical drug research • principal investigator: 24 years • investigator: 4 years

  11. What can DRUM offer sponsors State of the art conduct of early phase clinical studies • High quality • Large expertise • Short timelines • High flexibility • Fair cost

  12. Timelines (cfr DRUG) EC: Ethics Committee www.drug-uzgent.be

  13. What can DRUM offer sponsors State of the art conduct of early phase clinical studies • High quality • Large expertise • Short timelines • High flexibility • Fair cost

  14. High flexibility • Dose adjustments • Pharmacy with GMPz • Pharmacell bv with full GMP • Additional safety measures • Puts pressure on working hours/social environment of staff, particularly in the early years

  15. What can DRUM offer the MUMC • Service center for early phase drug investigations • Take advantage of knowledge center (experts in MUMC) • Facilitates education (training) in Medicine/ Health Sciences/clinical pharmacologist

  16. staff • Principal investigator - investigator - quality coordinator - managing coordinator - clinical research coordinator - trial nurse - office manager • investigator/principal investigator experienced in early phase studies • All are well-trained • training at DRUG • Highly motivated • Bank personnel: trial nurses / co-investigators

  17. facilities • 16 beds for clinical research and overnight stay • 2 sample handling laboratories (temperature controlled) • 1 drug storage room (temperature controlled / alarm) • 1 freezer (-18°C) + 1 (-70°C) temperature controlled / • alarm) • 2 refrigerators (temperature controlled / alarm) • offices, archive, meeting room, reception, kitchen, storage room

  18. facilities • 16 beds for clinical research and overnight stay • 2 sample handling laboratories (temperature controlled) • 1 drug storage room (temperature controlled / alarm) • 1 freezer (-18°C) + 1 (-70°C) temperature controlled / • alarm) • 2 refrigerators (temperature controlled / alarm) • offices, archive, meeting room, reception, kitchen, storage room

  19. facilities • 16 beds for clinical research and overnight stay • 2 sample handling laboratories (temperature controlled) • 1 drug storage room (temperature controlled / alarm) • 1 freezer (-18°C) + 1 (-70°C) temperature controlled / • alarm) • 2 refrigerators (temperature controlled / alarm) • offices, archive, meeting room, reception, kitchen, storage room

  20. Ready to start!

  21. Summary • Centre of Excellence • (qualified staff / approval / external audits / • ISO 9001:2008) • short timelines, high flexibility • takes advantage of university knowledge centre

  22. YES, we can!

More Related